This Week in HIV Research: Neurocognitive Symptoms Common During Acute HIV Infection, and Estimates of People Living With HIV in the U.S.
Barbara Jungwirth, TheBodyPRO.com; Posted Aug 26, 11:31 a.m. ET
This week, a study finds that mild neurocognitive symptoms are common during acute HIV infection, but disappear within a month of starting antiretroviral treatment. Another study reports that estimates for the number of people living with HIV in the U.S. may be too high.
Updated: Common Patient Assistance Program Application Reduces Barriers to HIV Medication Access
Murray Penner, AIDS.gov; Posted Aug 25, 4:35 p.m. ET
The updated Common Patient Assistance Program Application is intended to be used by both people living with HIV and their doctors or case managers) to apply to all HIV patient assistance programs at once, thus reducing the application paperwork and time.
Preparing for Disasters and Emergencies When Living With HIV
JD Davids and David Mendosa, TheBody.com; Posted Aug 25, 3:51 p.m. ET
It's important to not just think about the possibility of an emergency -- it's best to plan for it, especially if you are living with HIV or other chronic conditions.
Starting Treatment With a Low CD4 Count
Roger Pebody, TheBody.com; Posted Aug 25, 2:03 p.m. ET
Are you among the one-in-four people who received their HIV diagnosis when your immune system was already weakened? Is starting treatment right away the right thing to do? What can you expect in the coming months and years?
Everyone living with HIV has a story to tell. Find out how to share your own experiences in one or both of the series below, which feature the writings of readers like you.
Regardless of where or how it happened, the day you received your HIV-positive diagnosis was likely among the most intense days you'll ever live through. Some of TheBody.com's readers have generously shared their experiences -- to reflect on how they've changed, and so that others would know that they too can survive, and even thrive, following that fateful day. How did you get through it?
Many types of medications can save or improve lives, but they can also have unintended consequences. For some people living with HIV, taking meds can be a complicated cycle -- and for others, a Sunday stroll. Medication side effects can be mild or life altering, horrible or even pleasurable; some people living with HIV never experience any at all. It seems like everyone's got a story about side effects. What's yours?
What Do Vitamin D Levels at HIV Treatment Initiation Have to Do With CD4 Cell Count Recovery?
Olivia G. Ford, TheBodyPRO.com; Posted Aug 25, 11:55 a.m. ET
Alison Abraham, Ph.D., discusses her study of whether vitamin D levels at initiation of antiretroviral therapy are associated with the post-initiation plateau and rate of rise of CD4 count.
Food Insecurity Tied to HIV, Other STIs and Drug Use in U.S. Men
Mark Mascolini, TheBodyPRO.com; Posted Aug 25, 11:06 a.m. ET
A limited ability to access nutritious food independently predicted prevalent HIV infection, other sexually transmitted infections (STIs) and illicit drug use in a nationally representative sample of men in the U.S. general population, according to a recent study.
2016 National Ryan White Conference on HIV Care and Treatment: Day One Recap
AIDS.gov; Posted Aug 24, 1:58 p.m. ET
More than 2,400 HIV care and treatment leaders, Ryan White HIV/AIDS Program recipients, stakeholders, and those on the front lines providing direct care to people living with HIV convened in Washington, D.C. yesterday for the kickoff of the 2016 National Ryan White Conference on HIV Care & Treatment.
Could Tim Kaine's Faith Elevate Global HIV Funding?
Drew Gibson, TheBody.com; Posted Aug 24, 1:43 p.m. ET
George W. Bush's PEPFAR program expanded HIV treatment worldwide, but its future is disconcertingly precarious. Could the aisle-crossing Catholicism of Tim Kaine deliver desperately needed funds in a Clinton White House?
My Health Tracker can help you organize your HIV treatment information privately and securely in one place. This way, you can take better charge over your health, and you and your doctor can have even more productive conversations about your treatment.
Registration takes only a couple of minutes, requires no personal info, and you'll be able to pick up where you left off at any time.
Take Action: Urge Restock of Injectable Estrogen
Callen Lorde Health Center; Posted Aug 24, 12:40 p.m. ET
The impact of the injectable estrogen shortage, which began 18 months ago, poses a serious public health issue for transgender women across the country who rely on hormones to live whole and healthy lives.
Making PrEP More Integrated and Available for Primary Care Providers to Prescribe in the U.S. Southeast
Olivia G. Ford, TheBodyPRO.com; Posted Aug 24, 11:57 a.m. ET
Jessica Seidelman, M.D., and her Duke colleagues want to empower primary care providers in the U.S. Southeast to tell their patients, "[PrEP] is something that you can take.
Slow But Steady Increase in Kidney Risk Observed With TDF, Atazanavir, Lopinavir
Mark Mascolini, TheBodyPRO.com; Posted Aug 24, 11:37 a.m. ET
Each additional year of tenofovir disoproxil fumarate, ritonavir-boosted atazanavir or lopinavir was independently linked to higher incidence of chronic kidney disease in a 23,905-person cohort with initially normal renal function.
Ottawa Study Finds Nurse-Led PEP Clinic Works
Sean R. Hosein, Canadian AIDS Treatment Information Exchange; Posted Aug 23, 2:29 p.m. ET
Researchers in Ottawa conducted a two-year study based in sexual health clinics in the community where nurse-led programs assessed the demand for and use of PEP.
>> Browse Older Featured Stories